{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T12:31:55Z","timestamp":1771936315301,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>\n              <jats:italic>Mycobacterium simiae<\/jats:italic> is commonly found in people with weak immune systems such as the elderly and people with tuberculosis and other lung diseases. The aim of this study is the epidemiology of <jats:italic>M. simiae<\/jats:italic> infections in Iran and the world, therefore, in this study, analysis of relative gene expression and mutation of <jats:italic>pstB<\/jats:italic> and <jats:italic>efpA<\/jats:italic> efflux pumps in <jats:italic>Mycobacterium simiae<\/jats:italic> isolates from suspected tuberculosis patients by using Real-time quantitative PCR. Sixty-five sputa samples of suspected tuberculosis specimens were collected. The identification of NTM Species\u00a0by PCR sequencing and determining drug sensitivity by micro broth dilution method. The investigate mutations in <jats:italic>pstB<\/jats:italic> and <jats:italic>efpA<\/jats:italic> efflux pump genes using the PCR-sequencing method. Comparative evaluation of the replication efficiency of internal control gene 16SrDNA and target genes <jats:italic>pstB<\/jats:italic> and <jats:italic>efpA<\/jats:italic>.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In total, 15 isolates of <jats:italic>M. simiae<\/jats:italic> were evaluated and a drug sensitivity test was performed for them against the antibiotic ethambutol, moxifloxacin, clarithromycin, and linezolid. The highest resistance to moxifloxacin and linezolid antibiotics and the lowest resistance to clarithromycin antibiotics were observed. The results of expression levels of two efflux <jats:italic>PstB<\/jats:italic> and <jats:italic>efpA<\/jats:italic> showed that there was a significant difference in the expression level of the <jats:italic>efpA<\/jats:italic> efflux pump gene in <jats:italic>M. simiae<\/jats:italic> three-resistant and double-resistant isolates compared to the sensitive group and the standard.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The high level of antibiotic resistance In <jats:italic>M. simiae<\/jats:italic> isolates is an alarm and monitoring all factors related to antibiotic resistance, including efflux pumps, is an important research topic.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12866-025-03843-6","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:50:31Z","timestamp":1742172631000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Analysis of relative genes expression and mutation of pstB and efpA efflux pumps in Mycobacterium simiae isolates from suspected tuberculosis patients by using quantitative\u00a0Real-time  PCR"],"prefix":"10.1186","volume":"25","author":[{"given":"Mohammad","family":"Hashemzadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Hasanvand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Effat Abbasi","family":"Montazeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"3843_CR1","doi-asserted-by":"publisher","first-page":"1394220","DOI":"10.3389\/fmicb.2024.1394220","volume":"15","author":"LE Conyers","year":"2024","unstructured":"Conyers LE, Saunders BM. Treatment for non-tuberculous mycobacteria: challenges and prospects. Front Microbiol. 2024;15:1394220. https:\/\/doi.org\/10.3389\/fmicb.2024.1394220.","journal-title":"Front Microbiol"},{"key":"3843_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13568-023-01553-8","volume":"1","author":"M Hashemzadeh","year":"2023","unstructured":"Hashemzadeh M, Dezfuli AA, Khosravi AD, Bandbal MM, Ghorbani A, Hamed M, Dezfuli SK. Molecular identification of non-tuberculous mycobacterial species isolated from extrapulmonary samples using real-time PCR and rpoB sequence analysis. AMB Express. 2023;1:43. https:\/\/doi.org\/10.1186\/s13568-023-01553-8.","journal-title":"AMB Express"},{"issue":"4","key":"3843_CR3","doi-asserted-by":"publisher","first-page":"e1008418","DOI":"10.1371\/journal.ppat.1008418","volume":"16","author":"JF Jabbour","year":"2020","unstructured":"Jabbour JF, Hamieh A, Sharara SL, Kanj SS. Mycobacterium simiae: Harmless colonizer or deadly pathogen? PLoS path. 2020;16(4):e1008418. https:\/\/doi.org\/10.1371\/journal.ppat.1008418.","journal-title":"PLoS path"},{"issue":"2","key":"3843_CR4","doi-asserted-by":"publisher","first-page":"00773","DOI":"10.1183\/23120541.00773-2023","volume":"10","author":"N Wetzstein","year":"2024","unstructured":"Wetzstein N, Diricks M, Andres S, Kuhns M, Marschall L, Biciusca T, Smaczny C, Friesen I, Niemann S, Wichelhaus TA. Genomic diversity and clinical relevance of Mycobacterium simiae. ERJ Open Res. 2024;10(2):00773\u20132023. https:\/\/doi.org\/10.1183\/23120541.00773-2023.","journal-title":"ERJ Open Res"},{"key":"3843_CR5","doi-asserted-by":"publisher","unstructured":"Hamieh A, Tayyar R, Tabaja H, EL Zein S, Bou Khalil P, Kara N, Kanafani ZA, Kanj N, Bou Akl I, Araj G, Berjaoui G. Emergence of Mycobacterium simiae: A retrospective study from a tertiary care center in Lebanon. PloS one. 2018;13(4): e0195390.https:\/\/doi.org\/10.1371\/journal.pone.0195390","DOI":"10.1371\/journal.pone.0195390"},{"issue":"8","key":"3843_CR6","doi-asserted-by":"publisher","first-page":"e0267320","DOI":"10.1371\/journal.pone.0267320","volume":"17","author":"S Daneshfar","year":"2022","unstructured":"Daneshfar S, Khosravi AD, Hashemzadeh M. Drug susceptibility profiling and genetic determinants of drug resistance in Mycobacterium simiae isolates obtained from regional tuberculosis reference laboratories of Iran. PLoS One. 2022;17(8):e0267320. https:\/\/doi.org\/10.1371\/journal.pone.0267320.","journal-title":"PLoS One"},{"key":"3843_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40793-017-0291-x","volume":"13","author":"JL Steffani-Vallejo","year":"2018","unstructured":"Steffani-Vallejo JL, Brunck ME, Acosta-Cruz EY, Montiel R, Barona-G\u00f3mez F. Genomic insights into Mycobacterium simiae human colonization. Stand Genomic Sci. 2018;13:1\u20138. https:\/\/doi.org\/10.1186\/s40793-017-0291-x.","journal-title":"Stand Genomic Sci"},{"issue":"1","key":"3843_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/antibiotics9010018","volume":"9","author":"CM Bento","year":"2020","unstructured":"Bento CM, Gomes MS, Silva T. Looking beyond typical treatments for atypical mycobacteria. Antibiotics. 2020;9(1):18. https:\/\/doi.org\/10.3390\/antibiotics9010018.","journal-title":"Antibiotics"},{"issue":"7","key":"3843_CR9","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1080\/14787210.2022.2056019","volume":"20","author":"S Dashtbin","year":"2022","unstructured":"Dashtbin S, Mirkalantari S, Dadashi M, Darban-Sarokhalil D. Investigation of drug regimens and treatment outcome in patients with Mycobacterium Simiae: a systematic review. Expert Rev Anti Infect Ther. 2022;20(7):1015\u201323. https:\/\/doi.org\/10.1080\/14787210.2022.2056019.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"12","key":"3843_CR10","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.3390\/ijms21124191","volume":"21","author":"L Rindi","year":"2020","unstructured":"Rindi L. Efflux pump inhibitors against nontuberculous mycobacteria. Inter j mol sci. 2020;21(12):4191. https:\/\/doi.org\/10.3390\/ijms21124191.","journal-title":"Inter j mol sci"},{"issue":"5","key":"3843_CR11","doi-asserted-by":"publisher","first-page":"e01348","DOI":"10.1128\/aac.01348-23","volume":"68","author":"T Teng","year":"2024","unstructured":"Teng T, Chen S, Huo F, Jia J, Zhao L, Jiang G, Wang F, Chu N, Huang H. Efflux pump effects on levofloxacin resistance in Mycobacterium abscessus. Antimicrob Agents Chemother. 2024;68(5):e01348-e1423. https:\/\/doi.org\/10.1128\/aac.01348-23.","journal-title":"Antimicrob Agents Chemother"},{"key":"3843_CR12","doi-asserted-by":"crossref","unstructured":"van Ingen J. Drug susceptibility testing of nontuberculous mycobacteria. Nontuberculous Mycobacterial Disease: A Comprehensive Approach to Diagnosis and Management. 2019:61\u201388.","DOI":"10.1007\/978-3-319-93473-0_3"},{"issue":"3","key":"3843_CR13","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3390\/antibiotics8030153","volume":"8","author":"JS Vianna","year":"2019","unstructured":"Vianna JS, Machado D, Ramis IB, Silva FP, Bierhals DV, Abril MA, von Groll A, Ramos DF, Louren\u00e7o MC, Viveiros M, da Silva PE. The contribution of efflux pumps in Mycobacterium abscessus complex resistance to clarithromycin. Antibiotics. 2019;8(3):153. https:\/\/doi.org\/10.3390\/antibiotics8030153.","journal-title":"Antibiotics"},{"key":"3843_CR14","doi-asserted-by":"publisher","unstructured":"Datta D, Jamwal S, Jyoti N, Patnaik S, Kumar D. Actionable mechanisms of drug tolerance and resistance in Mycobacterium tuberculosis. The FEBS J. 2024 27. https:\/\/doi.org\/10.1111\/febs.17142","DOI":"10.1111\/febs.17142"},{"issue":"15","key":"3843_CR15","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.2174\/0115680266276938240108060247","volume":"24","author":"P Amruta Adhikrao","year":"2024","unstructured":"Amruta Adhikrao P, Mayuri Motiram G, Kumar G. Tackling nontuberculous mycobacteria by repurposable drugs and potential leads from natural products. Curr Top Med Chem. 2024;24(15):1291\u2013326. https:\/\/doi.org\/10.2174\/0115680266276938240108060247.","journal-title":"Curr Top Med Chem"},{"key":"3843_CR16","doi-asserted-by":"publisher","first-page":"e00107","DOI":"10.1016\/j.plabm.2018.e00107","volume":"12","author":"GS Bhalla","year":"2018","unstructured":"Bhalla GS, Sarao MS, Kalra D, Bandyopadhyay K, John AR. Methods of phenotypic identification of non-tuberculous mycobacteria. Pract Lab Med. 2018;12:e00107. https:\/\/doi.org\/10.1016\/j.plabm.2018.e00107.","journal-title":"Pract Lab Med"},{"issue":"12","key":"3843_CR17","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.1128\/jcm.41.12.5699-5708.2003","volume":"41","author":"T Ad\u00e9kambi","year":"2003","unstructured":"Ad\u00e9kambi T, Colson P, Drancourt M. rpoB-based identification of nonpigmented and late-pigmenting rapidly growing mycobacteria. J clin Microbiol. 2003;41(12):5699\u2013708. https:\/\/doi.org\/10.1128\/jcm.41.12.5699-5708.2003.","journal-title":"J clin Microbiol"},{"key":"3843_CR18","doi-asserted-by":"publisher","unstructured":"Hashemzadeh M, Asareh Zadegan Dezfuli A, Khosravi A, Ahmad Khosravi N, Saki M. Antibiotic resistance and genomic characterization of Mycobacterium abscessus complex isolates from patients with pulmonary tuberculosis in Iran: A multi-center study (2010\u20132021). Acta\u00a0Microbiol Immunol Hung. 2024;71(1):82-8. https:\/\/doi.org\/10.1556\/030.2024.02169.","DOI":"10.1556\/030.2024.02169"},{"key":"3843_CR19","unstructured":"Woods GL, Brown-Elliott BA, Conville PS, Desmond EP, Hall GS, Lin G, Pfyffer GE, Ridderhof JC, Siddiqi SH, Wallace Jr RJ, Warren NG. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes."},{"issue":"3","key":"3843_CR20","doi-asserted-by":"publisher","first-page":"e127866","DOI":"10.5812\/archcid-127866","volume":"17","author":"D Malekshahian","year":"2022","unstructured":"Malekshahian D, Tabarsi P, Farnia P, Javanmard P, Seif S, Teymouri H. Mycobacterium simiae Isolates Subtypes and Molecular Drug Susceptibility in Iran. Arch Clin Infect Dis. 2022;17(3):e127866. https:\/\/doi.org\/10.5812\/archcid-127866.","journal-title":"Arch Clin Infect Dis"},{"key":"3843_CR21","doi-asserted-by":"publisher","unstructured":"Hashemzadeh M, Zadegan Dezfuli AA, Khosravi AD, Ahmad Khosravi N, Hashemi Shahraki A. Frequency of mutations in erm (39) related to clarithromycin resistance and in rrl related to linezolid resistance in clinical isolates of Mycobacterium fortuitum in Iran. 2023;70(2):167-76. https:\/\/doi.org\/10.1556\/030.2023.02020","DOI":"10.1556\/030.2023.02020"},{"key":"3843_CR22","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1007\/s00284-021-02486-w","volume":"78","author":"H Dezhkhi","year":"2021","unstructured":"Dezhkhi H, Farnia P, Haddadi A, Farnia P, Velayati AA. Characterization of clinical isolates of Mycobacterium simiae using drug susceptibility tests and molecular analyses. Cur Microbiol. 2021;78:2324\u201331.","journal-title":"Cur Microbiol"},{"issue":"4","key":"3843_CR23","doi-asserted-by":"publisher","first-page":"619","DOI":"10.2174\/1871526520999200727114148","volume":"21","author":"MJ Nasiri","year":"2021","unstructured":"Nasiri MJ, Amini S, Nikpor Z, Arefzadeh S, Mousavi SM, Goudarzi H. Drug susceptibility testing of Mycobacterium simiae: An emerging pathogen in Iran. Infect Disord Drug Targets Infect Disord Drug Targets. 2021;21(4):619\u201322. https:\/\/doi.org\/10.2174\/1871526520999200727114148.","journal-title":"Infect Disord Drug Targets Infect Disord Drug Targets"},{"issue":"3","key":"3843_CR24","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1093\/labmed\/lmx025","volume":"48","author":"R Misra","year":"2017","unstructured":"Misra R, Jain V, Tejan N, Negi A, Umrao J, Dhole TN. Multi-drug-resistant surgical site infection due to Mycobacterium abscessus complex. Lab Med. 2017;48(3):e36-41. https:\/\/doi.org\/10.1093\/labmed\/lmx025.","journal-title":"Lab Med"},{"issue":"7","key":"3843_CR25","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.3389\/fmicb.2016.02097","volume":"26","author":"Y Li","year":"2016","unstructured":"Li Y, Pang Y, Tong X, Zheng H, Zhao Y, Wang C. Mycobacterium kansasii subtype I is associated with clarithromycin resistance in China. Front microbiol. 2016;26(7):2097. https:\/\/doi.org\/10.3389\/fmicb.2016.02097.","journal-title":"Front microbiol"},{"key":"3843_CR26","doi-asserted-by":"publisher","unstructured":"Matos AC, Figueira L, Martins MH, Cardoso L, Matos M, Pinto MD, Coelho AC. Mycobacterium avium subsp. paratuberculosis in Wild Boar (Sus scrofa) in Portugal. Pathogens. 2024 8;13(5):389. https:\/\/doi.org\/10.3390\/pathogens13050389","DOI":"10.3390\/pathogens13050389"},{"issue":"1","key":"3843_CR27","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3390\/antibiotics12010064","volume":"12","author":"M Fernandez-Pittol","year":"2022","unstructured":"Fernandez-Pittol M, Batista-Arnau S, Rom\u00e1n A, San Nicol\u00e1s L, Oliver L, Gonz\u00e1lez-Moreno O, Mart\u00ednez JA, Amaro-Rodr\u00edguez R, Soler N, Gen\u00e9 A, Gonz\u00e1lez-Cuevas A. Differences in drug-susceptibility patterns between Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium chimaera clinical isolates: Prospective 8.5-year analysis by three laboratories. Antibiotics. 2022;12(1):64. https:\/\/doi.org\/10.3390\/antibiotics12010064.","journal-title":"Antibiotics."},{"key":"3843_CR28","doi-asserted-by":"crossref","unstructured":"Kamau G, Mwangi Z, Bargul J, owiny M, Mukiri N, Kathure I, Khamala B, Mwanyalu N, Kiplimo R, Lihana R. Non-tuberculous mycobacterium isolations from tuberculosis presumptive cases at the National Tuberculosis Reference Laboratory Kenya, 2018\u201c2019. F1000Research. 2024;12:1104.","DOI":"10.12688\/f1000research.135106.2"},{"key":"3843_CR29","doi-asserted-by":"publisher","unstructured":"Li XZ, Zhang L, Nikaido H (2004) Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis.\u00a0Antimicrob\u00a0Agents\u00a0Chemother,\u00a048;2415-2423. https:\/\/doi.org\/10.12688\/f1000research.135106.1","DOI":"10.12688\/f1000research.135106.1"},{"issue":"11","key":"3843_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/aac.00262-21","volume":"65","author":"D Rai","year":"2021","unstructured":"Rai D, Mehra S. The mycobacterial efflux pump EfpA can induce high drug tolerance to many antituberculosis drugs, including moxifloxacin, in mycobacterium smegmatis. Antimicrob Agents Chemother. 2021;65(11):10\u2013128. https:\/\/doi.org\/10.1128\/aac.00262-21.","journal-title":"Antimicrob Agents Chemother"},{"key":"3843_CR31","unstructured":"Al-Sulami AA, Ali ZM, Al-Maleky DA. Rapid isolation and identification of Mycobacterium tuberculosis from pulmonary tuberculosis patients. Asian\u00a0Pac J Trop Med. 2(3):70\u201373."},{"key":"3843_CR32","doi-asserted-by":"crossref","unstructured":"van Ingen J, Brosch R, van Soolingen D. Characterization of Mycobacterium orygis. Emerg\u00a0infect dis,\u00a018, 653.","DOI":"10.3201\/eid1804.110888"}],"updated-by":[{"DOI":"10.1186\/s12866-025-03991-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000}}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-03843-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-025-03843-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-03843-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T06:04:00Z","timestamp":1745993040000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-025-03843-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3843"],"URL":"https:\/\/doi.org\/10.1186\/s12866-025-03843-6","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12866-025-03991-9","asserted-by":"object"}]},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"2 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: Following publication of the original article [1], the authors reported that the code of fund under the \u201cAcknowledgements\u201d and \u201cFunding\u201d sections, which is \u201c(Grant No. OG-9740)\u201d, is incorrect and should be replaced with \u201c(Grant No. OG-0132)\u201d; and also the code of ethics under the \u201cEthics approval and consent to participate\u201d section, which is \u201c(IR.AJUMS.REC.1397.829)\u201d, is incorrect and should be replaced with \u201c(IR.AJUMS.MEDICINE.REC.1401.063)\u201d.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12866-025-03991-9","URL":"https:\/\/doi.org\/10.1186\/s12866-025-03991-9","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was conducted according to the Helsinki Declaration. The study was approved by the Research Ethics Committee (REC) of the Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran, and the necessary permission was granted for specimen collection (IR.AJUMS.MEDICINE.REC.1401.063). This Research involving human participants has been performed following and with the Helsinki Declaration of 1964, as revised in 2013. The study was approved by the Research Ethics Committee (REC) of the Ahvaz Jundishapur University of Medical Sciences. Written Informed Consent was obtained from all the participants. After the submission of the preliminary proposal, and necessary permission for sample collection was granted. All respondents were asked to provide written consent to participate in the study. We emphasized that participation was voluntary and that patients could withdraw from the research at any time. Additionally, all procedures involving human participants confirmed that each individual had given written consent for the use of their information. In this study, personal information such as patients' names, surnames, ethnicity, personal identification numbers, and any other information that patients did not agree to have published were excluded. All participants provided informed consent for the research, and their anonymity was preserved throughout the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not all authors have a problem publishing an article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"144"}}